Ialugen Plus (Sulfadiazine Silver, Sodium Hyaluronate)

Silver sulfadiazine releases silver ions that bind to bacterial DNA and proteins, disrupting essential cellular functions and providing broad‑spectrum antimicrobial activity. In addition, sulfadiazine interferes with bacterial folic‑acid synthesis, further inhibiting microbial growth.

The dosage of Ialugen Plus is determined by the prescribing clinician based on the size and depth of the burn or wound. Typically, a thin layer is applied once or twice daily after proper wound cleaning, but exact frequency and amount should follow the healthcare professional’s instructions.

Safety data for Ialugen Plus in pregnancy and lactation are limited. Because systemic absorption of silver and sulfadiazine can occur, it should be used only if the potential benefit justifies any possible risk to the fetus or infant, and only under medical supervision.

To order Ialugen Plus, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Compared with standard silver sulfadiazine creams, Ialugen Plus adds sodium hyaluronate, which creates a hydrated matrix that can enhance wound healing and reduce scar formation. Unlike some antibiotic ointments, it offers broad antimicrobial coverage without relying on a single class of antibiotics, potentially lowering resistance risk.

Ialugen Plus should be stored at room temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from direct sunlight, and avoid exposure to moisture to maintain product stability.

After cleaning the burn or wound with sterile saline, apply a thin, even layer of Ialugen Plus to the affected area using sterile gloves or a gauze pad. Cover with a non‑adherent dressing if required, and re‑apply according to the clinician’s schedule, usually once or twice daily.

Serious risks include allergic contact dermatitis, systemic silver toxicity (argyria) with prolonged use, and rare severe hypersensitivity reactions such as Stevens‑Johnson syndrome. Patients should be monitored for signs of rash, swelling, or systemic symptoms, and the product should be discontinued if such reactions occur.

Ialugen Plus is contraindicated in individuals with known hypersensitivity to silver, sulfadiazine, or any sulfonamide. It should also be avoided on deep puncture wounds, compromised circulation areas, mucous membranes, and in patients with severe renal impairment without medical guidance.